FDA
-
-
-
-
-
-
-
Medivir's Partner Tango Therapeutics received FDA clearance to start the TNG348 phase 1/2 clinical study
-
-
-
-
-
-
-
IGM Biosciences Inc. (IGMS) and ADC Therapeutics (ADCT) Announce Clinical Collaboration over Imvotamab (IGM-2323)
-
-
-
-
-
-
-
IGM Biosciences Announces Third Quarter 2021 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
IGM Biosciences Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
IGM Biosciences Announces Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
251,611 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All